254 related articles for article (PubMed ID: 10903605)
1. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections.
Cohn SM; Lipsett PA; Buchman TG; Cheadle WG; Milsom JW; O'Marro S; Yellin AE; Jungerwirth S; Rochefort EV; Haverstock DC; Kowalsky SF
Ann Surg; 2000 Aug; 232(2):254-62. PubMed ID: 10903605
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infections.
Paladino JA; Gilliland-Johnson KK; Adelman MH; Cohn SM
Surg Infect (Larchmt); 2008 Jun; 9(3):325-33. PubMed ID: 18570574
[TBL] [Abstract][Full Text] [Related]
3. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
Solomkin JS; Reinhart HH; Dellinger EP; Bohnen JM; Rotstein OD; Vogel SB; Simms HH; Hill CS; Bjornson HS; Haverstock DC; Coulter HO; Echols RM
Ann Surg; 1996 Mar; 223(3):303-15. PubMed ID: 8604912
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections.
Wacha H; Warren B; Bassaris H; Nikolaidis P;
Surg Infect (Larchmt); 2006 Aug; 7(4):341-54. PubMed ID: 16978077
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
Malangoni MA; Song J; Herrington J; Choudhri S; Pertel P
Ann Surg; 2006 Aug; 244(2):204-11. PubMed ID: 16858182
[TBL] [Abstract][Full Text] [Related]
6. Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.
Maltezou HC; Nikolaidis P; Lebesii E; Dimitriou L; Androulakakis E; Kafetzis DA
Eur J Clin Microbiol Infect Dis; 2001 Sep; 20(9):643-6. PubMed ID: 11714046
[TBL] [Abstract][Full Text] [Related]
7. Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital.
Saltoglu N; Dalkiran A; Tetiker T; Bayram H; Tasova Y; Dalay C; Sert M
Clin Microbiol Infect; 2010 Aug; 16(8):1252-7. PubMed ID: 19832720
[TBL] [Abstract][Full Text] [Related]
8. The role of oral antimicrobials for the management of intra-abdominal infections.
Solomkin JS; Dellinger EP; Bohnen JM; Rostein OD
New Horiz; 1998 May; 6(2 Suppl):S46-52. PubMed ID: 9654311
[TBL] [Abstract][Full Text] [Related]
9. Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections.
Madan AK
Clin Ther; 2004 Oct; 26(10):1564-77. PubMed ID: 15598473
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
Zengin E; Sarper N; Kılıç SC
Pediatr Hematol Oncol; 2011 May; 28(4):311-20. PubMed ID: 21524156
[TBL] [Abstract][Full Text] [Related]
11. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Solomkin JS; Yellin AE; Rotstein OD; Christou NV; Dellinger EP; Tellado JM; Malafaia O; Fernandez A; Choe KA; Carides A; Satishchandran V; Teppler H;
Ann Surg; 2003 Feb; 237(2):235-45. PubMed ID: 12560782
[TBL] [Abstract][Full Text] [Related]
12. The use of piperacillin-tazobactam in neonatal and paediatric patients.
Wolf MF; Simon A
Expert Opin Drug Metab Toxicol; 2009 Jan; 5(1):57-69. PubMed ID: 19236229
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.
Gyssens IC; Dryden M; Kujath P; Nathwani D; Schaper N; Hampel B; Reimnitz P; Alder J; Arvis P
J Antimicrob Chemother; 2011 Nov; 66(11):2632-42. PubMed ID: 21896561
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
Walters DJ; Solomkin JS; Paladino JA
Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):551-61. PubMed ID: 10662480
[TBL] [Abstract][Full Text] [Related]
15. Antibiotics as first-line therapy for acute appendicitis: evidence for a change in clinical practice.
Hansson J; Körner U; Ludwigs K; Johnsson E; Jönsson C; Lundholm K
World J Surg; 2012 Sep; 36(9):2028-36. PubMed ID: 22569747
[TBL] [Abstract][Full Text] [Related]
16. Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
Solomkin J; Hershberger E; Miller B; Popejoy M; Friedland I; Steenbergen J; Yoon M; Collins S; Yuan G; Barie PS; Eckmann C
Clin Infect Dis; 2015 May; 60(10):1462-71. PubMed ID: 25670823
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study.
Schaper NC; Dryden M; Kujath P; Nathwani D; Arvis P; Reimnitz P; Alder J; Gyssens IC
Infection; 2013 Feb; 41(1):175-86. PubMed ID: 23180507
[TBL] [Abstract][Full Text] [Related]
18. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
[TBL] [Abstract][Full Text] [Related]
19. Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.
Philpott-Howard J; Burroughs A; Fisher N; Hastings M; Kibbler C; Mutimer D; Patch D; Rolando N; Wade J; Wendon J; O'Grady J
J Antimicrob Chemother; 2003 Dec; 52(6):993-1000. PubMed ID: 14585863
[TBL] [Abstract][Full Text] [Related]
20. Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
Namias N; Solomkin JS; Jensen EH; Tomassini JE; Abramson MA
Surg Infect (Larchmt); 2007 Feb; 8(1):15-28. PubMed ID: 17381394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]